Pathogenetic classification of a series of 27,145 consecutive infants with congenital defects

M L Martínez-Frías1, E Bermejo, J L Frías

  • 1Departamento de Farmacología, Facultad de Medicina, Universidad Complutense, Madrid, Spain. luisama@eucmos.sim.ucm.es

Insights

This study analyzed 27,145 infants with congenital defects, classifying them by errors of morphogenesis. Malformations were most common, but isolated disruptions occurred more frequently than isolated deformations.

Area of Science:

  • Pediatrics
  • Medical Genetics
  • Developmental Biology

Background:

  • Congenital defects are a significant concern in pediatrics.
  • Understanding the pathogenetic types of errors of morphogenesis is crucial for diagnosis and management.
  • Previous classifications have provided a framework for categorizing these anomalies.

Purpose of the Study:

  • To classify a large cohort of infants with congenital defects based on established pathogenetic types of errors of morphogenesis.
  • To determine the frequencies of malformations, deformations, and disruptions, both in isolation and in combination.
  • To highlight the clinical value of understanding these frequencies in evaluating congenital anomalies.

Main Methods:

  • Analysis of a consecutive series of 27,145 infants with congenital defects.
  • Classification of defects according to the pathogenetic types defined by the International Working Group.
  • Statistical calculation of the prevalence of different categories of errors of morphogenesis.

Main Results:

  • Malformations were identified in 97.94% of infants with congenital defects.
  • Deformations occurred in 3.92% and disruptions in 1.65% of infants.
  • Isolated disruptions (1.27%) were more common than isolated deformations (0.59%).

Conclusions:

  • Malformations are the most prevalent type of error of morphogenesis in infants.
  • While deformations are more common overall than disruptions, isolated disruptions are more frequent than isolated deformations.
  • Knowledge of the frequencies of these pathogenetic types is essential for the comprehensive evaluation of infants with congenital anomalies.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Mutations01:39

Mutations

Overview
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...